Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 4

1.

Long-term psychosocial outcomes of BRCA1/BRCA2 testing: differences across affected status and risk-reducing surgery choice.

Graves KD, Vegella P, Poggi EA, Peshkin BN, Tong A, Isaacs C, Finch C, Kelly S, Taylor KL, Luta G, Schwartz MD.

Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):445-55. doi: 10.1158/1055-9965.EPI-11-0991.

2.

Breast cancer in women at high risk: the role of rapid genetic testing for BRCA1 and -2 mutations and the consequences for treatment strategies.

Francken AB, Schouten PC, Bleiker EM, Linn SC, Rutgers EJ.

Breast. 2013 Oct;22(5):561-8. doi: 10.1016/j.breast.2013.07.045. Review.

PMID:
23972475
3.

Modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: systematic review and meta-analysis.

Friebel TM, Domchek SM, Rebbeck TR.

J Natl Cancer Inst. 2014 Jun;106(6):dju091. doi: 10.1093/jnci/dju091. Review. Erratum in: J Natl Cancer Inst. 2014 Aug;106(8):dju235 doi:10.1093/jnci/dju235.

4.

Psychological and Behavioral Impact of Participation in Ovarian Cancer Screening.

Andrykowski MA.

Diagnostics (Basel). 2017 Mar 8;7(1). pii: E15. doi: 10.3390/diagnostics7010015. Review.

Supplemental Content

Support Center